CDH1 and hepatocellular carcinoma: J.P. Zhang et al. [21] reported that miR-148a may promote the expression of an epithelial marker (E-cadherin), reduce the levels of mesenchymal markers (N-cadherin, fibronectin or vimentin), and negatively regulate MET/SNAIL signaling and in turn inhibit the EMT and metastasis of hepatoma cells.